Production (Stage)
Indaptus Therapeutics, Inc.
INDP
$0.3426
-$0.0007-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.89M | 5.79M | 7.38M | 7.30M | 9.74M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 669.70K | 681.60K | 236.60K | 180.40K | 436.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 400.20K | 150.00K | 12.10K | 6.30K | 114.70K |
| Total Current Assets | 4.96M | 6.62M | 7.63M | 7.49M | 10.29M |
|
|
|||||
| Total Current Assets | 4.96M | 6.62M | 7.63M | 7.49M | 10.29M |
| Net Property, Plant & Equipment | 58.10K | 82.20K | 105.70K | 128.60K | 151.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 392.60K | 638.30K | 504.70K | 504.70K | 504.70K |
| Total Assets | 5.41M | 7.34M | 8.24M | 8.12M | 10.95M |
|
|
|||||
| Total Accounts Payable | 1.31M | 870.20K | 555.90K | 416.60K | 405.50K |
| Total Accrued Expenses | 1.24M | 2.44M | 1.57M | 1.41M | 1.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 59.50K | 84.20K | 104.00K | 103.20K | 102.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.61M | 3.39M | 2.23M | 1.93M | 1.54M |
|
|
|||||
| Total Current Liabilities | 2.61M | 3.39M | 2.23M | 1.93M | 1.54M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 4.00K | 27.60K | 50.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.61M | 3.39M | 2.24M | 1.96M | 1.59M |
|
|
|||||
| Common Stock & APIC | 67.77M | 64.38M | 62.31M | 59.41M | 58.58M |
| Retained Earnings | -64.97M | -60.44M | -56.31M | -53.24M | -49.22M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.80M | 3.94M | 6.00M | 6.17M | 9.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.80M | 3.94M | 6.00M | 6.17M | 9.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.80M | 3.94M | 6.00M | 6.17M | 9.36M |
|
|
|||||